Sotuvning operatsion marjasi: ImmunityBio Inc (IBRX)

NantKwest (IBRX) kompaniyasining korporativ logotipi

Noyob saraton terapiyasining tijoratga chiqarilishi ImmunityBio, Inc. (IBRX) kompaniyasiga sezilarli narx belgilash imkoniyatini beradi. Operatsion foyda marjasi mahalliy dinamikani namoyish etmoqda, bunda ushbu ko'rsatkich hozirda -150.20 darajasida qat'iy belgilangan. T-hujayralarni faollashtirish orqali qovuq o'smalariga qarshi kurashishdagi yetakchilik vaksinalar yo'nalishidagi portfel diversifikatsiyasi bilan to'ldirilgan bo'lib, bu tartibga soluvchi xavflarni minimallashtiradi va kompaniyaning global bozoridagi mavjudligini kengaytiradi.

IBRX: immunitybio.com Operatsion foyda normasi 04.07.2022 - 19.11.2026

ImmunityBio, Inc. - tahliliy kesimlar va asosiy koʻrsatkichlar (IBRX)

- kompaniyaning birjadagi kapitallashuv ko'rsatkichlari:
Kompaniyaning asosiy tahlili:IBRX, ImmunityBio
NantKwest asosiy tovari

Operatsion marja moliyaviy majburiyatlar va soliqlarni hisobga olguncha, asosiy biznes jarayonlaridan foyda olish samaradorligini o'lchaydi va kompaniyaning daromadni operatsion foydaga aylantirish bo'yicha haqiqiy qobiliyatini aks ettiradi. ImmunityBio, Inc. (IBRX) uchun operatsion marja farqining tahlili uning noyob IL-15 terapiyasini tijoriyashtirish va NK-hujayralarini faollashtirish mexanizmlarining patent himoyasi xarajatlar tuzilmasini barqaror raqobatbardosh ustunlikka qanday aylantirayotganini ko'rsatadi va biznesning fundamental kuchini tasdiqlaydi.

ImmunityBio, Inc. kimlar bilan raqobatlashadi

Sotuvning operatsion marjasi IMCR|JANX - Operatsion foyda bo'yicha marjinallik|Sotuvning operatsion marjasi RCUS (Arcus Bio)|Operatsion foyda koeffitsiyenti ZYME|Operatsion marja TNGX (Tango Therapeutics, Inc.)|Operatsion foyda normasi IOVA|immatics.com - Operatsion marja|Sotuvning operatsion rentabelligi Xencor Inc.|Compass Therapeutics (CMPX) - Operatsion rentabellik|Replimune Group, Inc. - Operatsion foyda normasi|LYEL (lyell.com) - Operatsion marja|Operatsion marja Innate Pharma SA|Operatsion rentabellik pyxisoncology.com (PYXS)|CGEN: Operatsion foyda marjasi|IO Biotech Inc - Sotuvning operatsion marjasi|sutrobio.com (STRO) - Sotuvning operatsion rentabelligi|INKT - Operatsion rentabellik|werewolftx.com (HOWL) - Sotuvning operatsion marjasi|Immix (IMMX) - Operatsion rentabellik|ALXO (ALX Oncology Holdings) - Operatsion rentabellik|Sotuvning operatsion marjasi CUE|PDS Biotechnology Corporation (PDSB) - Operatsion faoliyat rentabelligi|Operatsion rentabellik Sonnet BioTherapeutics Holdings Inc. (SONN)|Operatsion marja MAIA Biotechnology Inc (MAIA)|Operatsion rentabellik Liminatus Pharma LIMN|Operatsion foyda normasi LVTX|NXTC: Sotuvning operatsion marjasi|leaptx.com - Operatsion foyda koeffitsiyenti|INTS: Operatsion marja|Sensei Biotherapeutics Inc - Operatsion foyda normasi|Sotuvning operatsion marjasi TOVX|Operatsion foyda bo'yicha sotuv rentabelligi GRTS (Gritstone bio, Inc.)|Sotuvning operatsion marjasi KA (kinetabio.com)|NEXI - Sotuvning operatsion rentabelligi|Turnstone Biologics - Sotuvning operatsion marjasi|Operatsion faoliyat rentabelligi Vaccinex Inc. (VCNX)|harpoontx.com - Operatsion marja